Serum pyrrolidone carboxypeptidase activity in N-methyl nitrosourea induced rat breast cancer

Hormone and Metabolic Research

Volumn 35, Issue 8, 2003, Pages 502-505

  Carrera, M P ^a   Ramirez Exposito M J ^a   Valenzuela, M T ^b   Garcia M J ^a   Mayas, M D ^a   Martinez Martos J M ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

GnRH; Mammary gland; NMU; Pyroglutamyl aminopeptidase; Tumour growth parameters

Indexed keywords

2 PYRROLIDONE DERIVATIVE; AMIDE; METHYLNITROSOUREA; PYROGLUTAMYL BETA NAPHTHYLAMIDE; PYRROLIDONE CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; BREAST CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; MULTIPLE REGRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME;

ANIMALS; BODY WEIGHT; BREAST NEOPLASMS; CARCINOGENS; FEMALE; METHYLNITROSOUREA; PYROGLUTAMYL-PEPTIDASE I; RATS; RATS, WISTAR; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 0141786948     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41809     Document Type: Article

References (20)

1. Flötotto T, Djahansouzi S, Gläser M, Hanstein B, Niederacher D, Brumm C, Beckman MW. Hormones and hormone antagonist: mechanisms of action in carcinogénesis of endometrial and breast cancer. Horm Metab Res 2001; 33: 451-457
2. Imagawa W, Pedchenko VK, Helber J, Zhang H. Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002; 80: 213-230
3. Zajchowski D, Sajer R, Webster L. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 1993; 53: 5004-5011
4. Jordan VC. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogen: Problem and potential for future clinical applications. Breast Cancer Res Treat 1983; 3: 73-86
5. Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000; 5: 187-200
6. Gullino PM, Pettigrew HM, Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 1975; 54: 401-414
7. Thompson HJ, Adlakha H. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res 1991; 51: 3412-3415
8. McCormick DL, Adamowski CB, Filks A, Moon RC. Lifetime dose-response relationship of mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 1981; 41: 1690-1694
9. Welsch CW. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: A review and tribute to Charles Breton Huggins. Cancer Res 1985; 45: 3415-3443
10. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Biology of disease; Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990; 62: 244-278
11. Beynon R, Bond J. Proteolytic Enzymes New York: Oxford University Press, 2001
12. Cummins PM, O'Connor B. Pyroglutamyl peptidase; an overview of the three known enzymatic forms. Biochim Biophys Acta 1998; 429: 1-17
13. Martínez JM, Prieto I, Ramírez MJ, Cueva C, Alba F, Ramírez M. Amino-peptidase activities in breast cancer tissue. Clin Chem 1999; 45: 1797-1802
14. Rivera ES, Andrade N, Martin G, Melito G, Cricco G, Mohamad N, Davio C, Caro R, Bergoc RM. Induction of mammary tumors in rat by intraperitoneal inyection of NMU; histopathology and estral cycle influence. Cancer Lett 1994; 86: 223-228
15. Martínez JM, Ramírez MJ, Prieto I, Petzelt C, Hermoso F, Alba F, Arias Saavedra JM, Ramírez M. Human serum pyroglutamyl-β -naphthylamide hidrolyzing activity during development and aging. Arch Gerontol Geriat 1999; 28: 31-36
16. Kottler ML, Starzec A, Carte MC, Lagarde JP, Martin A, Counis R. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int J Cancer 1997; 71: 595-599
17. Moriya T, Suzuki T, Pilichowska M, Ariga N, Kimura N, Ouchi N, Nagura H, Sasanu H. Inmunochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma. Pathol Int 2001; 51: 333-337
18. Paradiso A, Pezzetta A, Cellamare G, Shittulli F, Marzullo F, Reshkin SJ. GnRH receptors in human breast cancer and its contiguous not-involved breast tissue. J Endocrinol Invest 2000; 23: 90-96
19. Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001; 358: 1793-1803
20. Russo J, Russo IH. Influence of differentiation and cell kinetics in the susceptibility of rat mammary gland to carcinogenesis. Cancer Res 1980; 40: 2677-2687